中文 
别名:FRAT-1应用:WB,ICC,IP
反应种属:Human
规格：50μl/100μl
| Description |
|---|
| Positively regulates the Wnt signaling pathway by stabilizing beta-catenin through the association with GSK-3. May play a role in tumor progression and collaborate with PIM1 and MYC in lymphomagenesis. |
| Specification | |
|---|---|
| Aliases | FRAT-1 |
| Entrez GeneID | 10023 |
| Swissprot | Q92837 |
| WB Predicted band size | Calculated MW: 29 kDa; Observed MW: 29 kDa |
| Host/Isotype | Rabbit IgG |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | A synthetic peptide of human FRAT1 |
| Formulation | 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA |
| Application | |
|---|---|
| IP | 1/20 |
| WB | 1/500-1/1000 |
| ICC | 1/50-1/200 |
 |
Western blot analysis of FRAT1 in K562, Hela lysates using FRAT1 antibody. |
 |
Immunocytochemistry analysis of FRAT1 (green) in LNcap using FRAT1 antibody,and DAPI(blue). |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
发表回复